Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) EPS (Weighted Average and Diluted) (2021 - 2023)

Historic EPS (Weighted Average and Diluted) for Therapeutics (RAPT) over the last 3 years, with Q4 2023 value amounting to -$0.87.

  • Therapeutics' EPS (Weighted Average and Diluted) fell 3329.56% to -$0.87 in Q4 2023 from the same period last year, while for Sep 2024 it was -$0.85, marking a year-over-year increase of 7230.94%. This contributed to the annual value of -$3.31 for FY2023, which is 2845.9% down from last year.
  • According to the latest figures from Q4 2023, Therapeutics' EPS (Weighted Average and Diluted) is -$0.87, which was down 3329.56% from -$0.88 recorded in Q3 2023.
  • Therapeutics' 5-year EPS (Weighted Average and Diluted) high stood at -$0.61 for Q4 2021, and its period low was -$0.88 during Q3 2023.
  • For the 3-year period, Therapeutics' EPS (Weighted Average and Diluted) averaged around -$0.71, with its median value being -$0.65 (2022).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 158.73% in 2022, then tumbled by 4036.09% in 2023.
  • Over the past 3 years, Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.61 in 2021, then fell by 6.56% to -$0.65 in 2022, then tumbled by 33.3% to -$0.87 in 2023.
  • Its EPS (Weighted Average and Diluted) was -$0.87 in Q4 2023, compared to -$0.88 in Q3 2023 and -$0.74 in Q2 2023.